1. Home
  2. PIM vs RCEL Comparison

PIM vs RCEL Comparison

Compare PIM & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Putnam Master Intermediate Income Trust

PIM

Putnam Master Intermediate Income Trust

HOLD

Current Price

$3.30

Market Cap

159.5M

Sector

Finance

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.90

Market Cap

132.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PIM
RCEL
Founded
1988
N/A
Country
United States
United States
Employees
N/A
226
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.5M
132.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PIM
RCEL
Price
$3.30
$3.90
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
149.8K
162.4K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
8.28%
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17.17
Revenue Next Year
N/A
$49.82
P/E Ratio
$66.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.14
$3.22
52 Week High
$3.50
$10.28

Technical Indicators

Market Signals
Indicator
PIM
RCEL
Relative Strength Index (RSI) 58.45 42.45
Support Level $3.28 $3.84
Resistance Level $3.38 $4.09
Average True Range (ATR) 0.05 0.24
MACD 0.02 -0.04
Stochastic Oscillator 79.22 28.39

Price Performance

Historical Comparison
PIM
RCEL

About PIM Putnam Master Intermediate Income Trust

Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: